Celcuity Inc (CELC) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Celcuity Inc   (NASDAQ: CELC)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Celcuity Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Celcuity Inc's ROI in the second quarter of 2026?
Celcuity Inc recorded a cumulative net loss of $-226 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -45.41%.

Within the Healthcare sector 453 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3302 to 3782.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 186.22 % 90.72 % 67.69 % 44.4 % 0.59 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 741 377 439 437 144
Return On Investment (TTM) -45.41 % -55.22 % -58.75 % -66.29 % -85.35 %
CELC's Overall Ranking # 3782 # 3302 # 3380 # 3298 # 3212
Seq. Investment Change TTM 42.78 % 15.91 % 22.76 % 40.89 % -4.86 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -226 -193 -177 -163 -149




Return On Investment CELC's Ranking
Within: No.
Industry # 26
Sector # 454
Overall # 3782

Return On Investment Statistics
High Average Low
-12.34 %
-47 %
-85.58 %
(Jun 30 2018)   (Jun 30 2021)







Financial Statements
Celcuity Inc's II. Quarter Investments $ 741 Millions CELC's Balance sheet
Celcuity Inc's II. Quarter Income $ -79 Millions Quarterly CELC's Income Statement
CELC's Income by Division See CELC's Income by Division


CELC Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 422 213 177 169 83
Y / Y Investment Growth 97.94 % 20.54 % 4.87 % 102.42 % 608.5 %
Net Income in Millions -177 -112 -64 -40 -30
Y / Y Net Income Growth - - - - -
Annual Return On Investment -41.91 % -52.38 % -36.03 % -23.91 % -35.5 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CELC's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CELC's Competitors
Subscribers only: Roi for Celcuity Inc's Suppliers
Subscribers only: Return On Investment for CELC's Customers

Other Ratios
CELC's Roa CELC's Inventory Turnover Ratio CELC's Growth Rates CELC's Dividend Statistics
CELC's Profitability Ratios CELC's Asset Turnover Ratio CELC's Dividend Growth
CELC's Roe CELC's Valuation Ratios CELC's Financial Strength Ratios CELC's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI


Date modified: 2026-09-26T07:32:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.